Furthermore, in an experimental model of cerebral ischemia, it was shown that the protective effects of erythropoietin (EPO), which is capable of reducing BBB disruption and neuronal death, depend on a mechanism involving Cx43 phosphorylation, although the level of Cx43 was not modulated. This evidence concerns the gene GJA1 and brain ischemia.